CanceRX: New Approaches to Commercializing Biomedical Research

A conference that focused exclusively on new approaches to commercializing biomedical research in oncology through financial engineering. Bringing together representatives from key stakeholder communities—including academia and medical research centers, community hospitals, the biopharma industry, health plans, government agencies, patient advocacy groups, investment banks, hedge funds, credit rating agencies, biotech venture capitalists, and institutional and retail investors—the conference was organized into six sessions, each focusing on a specific aspect of the conference theme: (1) Scientific and Engineering Challenges; (2) New Business Models; (3) Financing Structure, Marketing, and Investor Concerns; (4) Government, Healthcare Reform, and Non-Profits; (5)Technology Licensing and Intellectual Property Issues; and (6) Credit Models and Debt Rating.